Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer-Nadim Study-SLCG

dc.contributor.authorProvencio, M.
dc.contributor.authorNadal, E.
dc.contributor.authorInsa, A.
dc.contributor.authorCampelo, R. Garcia
dc.contributor.authorHuidobro, G. G.
dc.contributor.authorDomine, M.
dc.contributor.authorMajem, M.
dc.contributor.authorRodriguez-Abreu, D.
dc.contributor.authorCalvo, V.
dc.contributor.authorMartinez-Marti, A.
dc.contributor.authorDe Castro, J.
dc.contributor.authorCobo Dols, M.
dc.contributor.authorLopez-Vivanco, G.
dc.contributor.authorDel Barco, E.
dc.contributor.authorBernabe, R.
dc.contributor.authorVinolas, N.
dc.contributor.authorBarneto, I.
dc.contributor.authorMassuti, B.
dc.contributor.authoraffiliation[Provencio, M.] Hosp Puerta Hierro, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Calvo, V.] Hosp Puerta Hierro, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Nadal, E.] Catalan Inst Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Insa, A.] Hosp Univ Clin Valencia, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Campelo, R. Garcia] Hosp Univ A Coruna, La Coruna, Spain
dc.contributor.authoraffiliation[Huidobro, G. G.] Complejo Hosp Vigo, Med Oncol, Vigo, Spain
dc.contributor.authoraffiliation[Domine, M.] Fdn Jimenez Diaz, Madrid, Spain
dc.contributor.authoraffiliation[Majem, M.] Hop La Santa Creu & St Pau, Barcelona, Spain
dc.contributor.authoraffiliation[Rodriguez-Abreu, D.] Hosital Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Martinez-Marti, A.] Hosp Valle De Hebron, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[De Castro, J.] Hosp Univ La Paz, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Cobo Dols, M.] Hosp Reg Univ Carlos Haya, Malaga, Spain
dc.contributor.authoraffiliation[Lopez-Vivanco, G.] Hosp Cruces, Bilbao, Spain
dc.contributor.authoraffiliation[Del Barco, E.] Hosp Univ Salamanca, Med Oncol, Salamanca, Spain
dc.contributor.authoraffiliation[Bernabe, R.] Hosp Univ Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Vinolas, N.] Hosp Clin Barcelona, Med Oncolopgy, Barcelona, Spain
dc.contributor.authoraffiliation[Barneto, I.] Hosp Reina Sofia, Oncol Med, Cordoba, Spain
dc.contributor.authoraffiliation[Massuti, B.] Alicante Univ Hosp, Med Oncol, Alicante, Spain
dc.date.accessioned2025-01-07T13:39:21Z
dc.date.available2025-01-07T13:39:21Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jtho.2018.08.236
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418311948/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25727
dc.identifier.wosID454014500220
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS320-S320
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectchemo/inmmunotherapy
dc.subjectneoadjuvant
dc.subjectNSCLC
dc.titlePhase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer-Nadim Study-SLCG
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files